Skip to main content
Clinical Trials/NL-OMON46897
NL-OMON46897
Completed
Not Applicable

Cognitive Behavioural Therapy for anxiety disorders in patients with Parkinson*s disease: a Randomized, Controlled Trial of the clinical effectiveness and changes in cerebral connectivity - Cognitive behavioural therapy for anxiety disorders in PD

Medisch Universitair Ziekenhuis Maastricht0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • \* Idiopathic PD according to the Queens Square Brain Bank diagnostic criteria
  • \* Presence of clinically relevant anxiety symptoms
  • \* Using a stable dose of levodopa or other antiparkinsonian medication for at least one month
  • \* No other current psychological treatment for anxiety; pharmacotherapy (e.g., SSRIs) is allowed if a stable dose is used at least 2 months prior to participation and the patient still meets inclusion criteria. During the trial the dosage should not be changed. Medication use and mental health care will be tracked throughout the study.
  • \* Age between 35 and 80 years
  • \* Signed informed consent

Exclusion Criteria

  • \* Parkinsonian syndromes or neurodegenerative disorders other than PD
  • \* Dementia or severe cognitive decline
  • \* Major depressive disorder (MDD) as defined by the criteria of a DSM\-V diagnosis for MDD
  • \* Abuse of alcohol, drugs or benzodiazepines.

Outcomes

Primary Outcomes

Not specified

Similar Trials